Claritev (NYSE:CTEV) was upgraded by analysts at Wells Fargo & Company to a "hold" rating.
Claritev (NYSE:CTEV) is now covered by analysts at Guggenheim. They set a "buy" rating and a $43.00 price target on the stock.
Claritev (NYSE:CTEV) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $63.00. They now have a "buy" rating on the stock.
Claritev (NYSE:CTEV) was given a new $33.00 price target on by analysts at Wells Fargo & Company.
Claritev Corporation to Present at J.P. Morgan Healthcare Conference